Imagine starting your day with a quick, digestible summary of the most important tech conversations happening on Hacker News. That’s the promise of a daily tech update. These digests cut through the ...
Figma expanded its AI-powered prototyping tool Figma Make on Feb. 20, introducing custom Model Context Protocol (MCP) connector support alongside certified connectors for Amplitude, Box, Dovetail, ...
For the quarter ended Dec. 31, Figma reported adjusted earnings per share of eight cents, up from six cents per share in the ...
Figma had 40% growth and a 7.9X forward P/S as AI spending led to an 8% margin contraction in 2026. Find out exactly why the FIG stock is a sell.
The graphic design software stock was one of 2025’s hottest IPOs. But the shares have plunged since then.
As the MDGs era comes to a conclusion with the end of the year, 2016 ushers in the official launch of the bold and transformative 2030 Agenda for Sustainable Development adopted by world leaders last ...
FinanceBuzz on MSN
10 high-paying part-time jobs where you can earn at least $40 an hour
Looking for a part-time job that pays $40 or more per hour? These 10 roles offer high pay, flexible hours, and the chance to boost your income on your terms.
Held every year on 21 May, UNESCO leads the celebration of World Day for Cultural Diversity for Dialogue and Development highlighting not only the richness of the world’s cultures, but also the ...
Development needs to be economically, socially and environmentally sustainable. The IMF helps countries around the world achieve the SDGs by working with them to develop the foundation for strong, ...
TIOBE Index for February 2026: Top 10 Most Popular Programming Languages Your email has been sent February’s TIOBE Index shows a leaderboard that looks steady at first glance, but small shifts beneath ...
What Are the Piaget Stages of Development? Piaget's stages of development are part of a theory about the phases of normal intellectual development from infancy through adulthood, including thought, ...
EGFR-targeted therapy is often used in patients with EGFR-driven cancer but is limited by on-target/off-tumor toxicities. Here, the authors develop a bispecific antibody targeting both EGFR and B7-H3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results